Initial combination therapy of ambrisentan and tadalafil and quality of life: SF-36 & camphor analyses from the ambition trial

Authors
Category Primary study
ConferenceAmerican Journal of Respiratory and Critical Care Medicine
Year 2017
This article has no abstract
Epistemonikos ID: 0ca3eb78ad2ad60fef752ad7416cbb9da7382e38
First added on: Apr 29, 2026